Supplementary Report will be subject of public meeting of New England Comparative Effectiveness Public Advisory Council (CEPAC) on December 6, 2012
Boston, Mass., November 19, 2012 – The Institute for Clinical and Economic Review (ICER) has posted the draft supplementary report “Diagnosis and Treatment of Obstructive Sleep Apnea in Adults” as a complement to the full review of the same name from the Agency for Healthcare Research and Quality (AHRQ). Both will be the subject of deliberation and vote at the next public meeting of the New England Comparative Effectiveness Public Advisory Council (CEPAC) on Thursday, December 6, 2012 in Hartford, Connecticut. The report prepared for CEPAC includes supplementary analyses to the original AHRQ review, including budget impact and cost-effectiveness analyses.
This supplementary report aims to help the members of CEPAC, and the public, understand the latest evidence on the relative effectiveness and value of different management options for adults with obstructive sleep apnea. The report will be available for public comments until Monday, November 26, 2012.
Meeting Details
Date: Thursday, December 6, 2012
Time: 10:00 AM – 4:00 PM ET
Legislative Office Building
Room 2D
300 Capitol Avenue
Hartford, CT 06106
Members of the public wishing to attend the meeting must register by December 4, 2012 by visiting the “Contact Us” section of The website also includes instructions for those wishing to submit written comments ahead of time, and those requesting the opportunity to make public comments at the meeting. Members of the public wishing to deliver an oral comment during the public meeting must register to do so no later than Thursday, November 29, 2012. An audio recording of the CEPAC meeting will be made available on the CEPAC website following the meeting for members of the public unable to attend the in-person meeting.
CEPAC is a regional body whose goal is to provide objective, independent guidance on the application of medical evidence to clinical practice and payer policy decisions across New England. Supported by a federal grant from the Agency for Healthcare Research and Quality (AHRQ), and with backing from a consortium of New England state health policy leaders, CEPAC holds public meetings to consider evidence reviews of medical tests and treatments and provide judgments regarding how the evidence can best be used across New England to improve the quality and value of healthcare services. CEPAC consists of practicing physicians with experience in evaluating and using evidence in the practice of healthcare, methodological experts, as well as patient/public members with experience in health policy, patient advocacy and public health. ICER manages the day-to-day operations of CEPAC with the input of a multi-stakeholder Advisory Board. A list of CEPAC members and Advisory Board members, as well as other information about the project, is available online at
About ICER
The Institute for Clinical and Economic Review (ICER), based at the Massachusetts General Hospital’s Institute for Technology Assessment (ITA) and an affiliate of Harvard Medical School, provides independent evaluation of the clinical effectiveness and comparative value of new and emerging technologies. ICER seeks to achieve its ultimate mission of informing public policy and spurring innovation in the use of evidence to improve the value of health care for all. For more information, please visit